Table 2 The treatment of 0-14-year-old children living with HIV in Ganzhou, China
Patient no. | Duration of diagnosis to first ART (months) | Initial ART regimen | Follow-up duration(months) | AIDS-related opportunistic infections | Cotrimoxazole | Current ART regimen | Current status |
|---|---|---|---|---|---|---|---|
GZ5F1 | 32 | 3TC/AZT + NVP | 77 | - | Not | 3TC/AZT + NVP | Follow-up |
GZ5F2 | 27 | 3TC + AZT + EFV | 89 | - | Access | 3TC + AZT + EFV | Follow-up |
GZ8F3 | 1 | 3TC + ABC + EFV | 31 | - | Not | 3TC/AZT + EFV | Follow-up |
GZ8F4 | 71 | 3TC + AZT + NVP | 34 | - | Access | 3TC/AZT + NVP | Follow-up |
GZ13F5 | 3 | 3TC + TDF + EFV | 28 | Skin lesions | Access | 3TC + TDF + EFV | Follow-up |
GZ1M6 | 3 | 3TC + AZT + NVP | 124 | Bacterial pneumonia; Pneumocystis carinii pneumonia | Not | 3TC + AZT + NVP | Follow-up |
GZ2M7 | 4 | 3TC + AZT + NVP | 116 | - | Access | 3TC + AZT + LPV/r | Follow-up |
GZ4M8 | 14 | D4T | 1 | - | Not | D4T | Dead |
GZ5M9 | 2 | 3TC + AZT + NVP | 129 | Bacterial pneumonia | Not | 3TC/AZT + NVP | Follow-up |
GZ6M10 | 69 | 3TC + AZT + NVP | 28 | - | Not | 3TC + AZT + NVP | Follow-up |
GZ8M11 | 20 | 3TC + AZT + EFV | 3 | - | Not | 3TC + AZT + EFV | Loss to follow-up |